TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pfizer Anti-Infectives AB
Closing information (x1000 NOK)
| Closing information | 2023/11 | 2022/11 | 2021/11 |
| Turnover |
2,168,842
|
1,280,955
|
330,539 |
| Financial expenses |
0
|
447
|
1,267 |
| Earnings before taxes |
1,036,241
|
392,998
|
-567,272 |
| EBITDA |
1,069,283
|
449,477
|
-506,808 |
| Total assets |
2,577,192
|
1,496,197
|
1,142,811 |
| Current assets |
68,280
|
106,356
|
217,702 |
| Current liabilities |
775,281
|
592,261
|
517,453 |
| Equity capital |
1,801,911
|
903,936
|
625,358 |
| - share capital |
51
|
47
|
50 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Solvency |
69.9%
|
60.4%
|
54.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
47.8%
|
30.7%
|
-171.6% |
| Return on assets (ROA) |
40.2%
|
26.3%
|
-49.5% |
| Current ratio |
8.8%
|
18.0%
|
42.1% |
| Return on equity (ROE) |
57.5%
|
43.5%
|
-90.7% |
| Change turnover |
781,334
|
968,092
|
-1,197,883 |
| Change turnover % |
56%
|
309%
|
-78% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.